BUZZ-U.S. STOCKS ON THE MOVE- Conatus, oil stocks, Stereotaxis

(Adds Cerus, Isis, Conatus, Stereotaxis (NasdaqCM: STXS - news) ) (For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)

U.S. stocks opened lower on Monday as volume returned to markets after the New Year holiday, with energy shares sliding again as crude prices fell to fresh 5-1/2 year lows. The Dow Jones industrial average was down 0.77 percent at 17,695.17, the S&P 500 was down 0.79 percent at 2,041.85 and the Nasdaq Composite was down 26.28 points, or 0.56 percent, to 4,700.54

** STEREOTAXIS INC, $2.0623, +33.92 pct

The U.S. Food and Drug Administration approved the medical device maker's catheter device, Vdrive with catheter advancement system, for sale in the country.

The company also received an approval from Japan Pharmaceuticals and Medical Devices Agency for Odyssey data management products.

** CONATUS PHARMACEUTICALS INC (NasdaqGM: CNAT - news) , $10.7391, +32.75 pct

The biotechnology company said it would present results from three clinical trials of its lead drug Emricasan on Thursday. Conatus said it would present results from a mid-stage study of the drug in patients with acute-on-chronic liver failure.

** CERUS CORP, $6.7599, +3.76 pct

The biomedical product maker said red blood cells treated with its Intercept Blood System for acute anemia in cardiovascular surgery patients met the main goal in an European late-stage trial.

** ISIS PHARMACEUTICALS INC (Stuttgart: ISI.SG - news) , $63.13, +2.53 pct

Johnson & Johnson (NYSE: JNJ - news) will pay the biotech company up to $835 million for an option to license three drugs targeting autoimmune diseases in the bowel.

** BRAINSTORM CELL THERAPEUTICS INC (NasdaqCM: BCLI - news) , $5.768, -23.09 pct

The Israeli stem cell therapy developer's stock rose 93 percent in past two trading days as data on mid-stage study of the company's stem cell therapy in patients with amytrophic lateral sclerosis is expected on Monday.

** ROYAL DUTCH SHELL PLC (Xetra: R6C1.DE - news) , $64.44, -3.79 pct

** TOTAL SA (Paris: FR0000120271 - news) , $48.58, -5.04 pct

** BP PLC, $36.31, -4.75 pct

** STATOIL ASA (Xetra: 675213 - news) , $16.62, -4.59 pct

** VALE SA, $7.61, -4.16 pct

** BHP BILLITON LTD, $45.86, -3.53 pct

** EXXON MOBIL CORP, $91.46, -1.48 pct

** CHEVRON CORP, $110.18, -2.13 pct

** PETROBRAS SA, $6.24, -7.69 pct

U.S.-listed stocks of the world's biggest oil and gas producers were down premarket after oil prices dropped to fresh five-and-a-half-year lows. Oil prices have been dipping on concerns over a surplus of global supplies and lackluster demand, losing more than half their value since a peak in June last year.

** CEMPRA INC (NasdaqGS: CEMP - news) , $24.86, +8.61 pct

The antibiotic drug developer moved a step closer to approval of its lead antibiotic, solithromycin, after an oral version of the potential blockbuster met the main goal in a late-stage trial.

** NATIONAL BANK OF GREECE SA, $1.7, -7.61 pct

Political uncertainty in Greece may force the European Central Bank to start quantitative easing as debate around the possibility of elections later this month resulting in the country leaving the euro zone picked up again.

Euro fell to $1.18605 in early Asian trading on Monday, its weakest level since March 2006.

** BREITBURN ENERGY PARTNERS LP, $7.52, -1.44 pct

The oil and gas company said on Friday it expected 2015 production of 19.5-20.7 million barrels of oil equivalent (boe), up from an estimated 14.1 million boe for 2014. Breitburn forecast oil and gas capital expenses to fall to $200 million in 2015 from an estimated $375 million in 2014.

** NOVARTIS AG (Xetra: 904278 - news) , $92.94, +0.75 pct

** AMGEN INC (Xetra: 867900 - news) , $157.39, -1.56 pct

Staff at the U.S. Food and Drug Administration are expected to review Novartis' application to market a copycat version of Amgen's biotech medicine Neupogen in patients with low white blood cell counts.

** MICROSOFT CORP, $46.69, -0.15 pct

** YAHOO INC (NasdaqGS: YHOO - news) , $49.7975, -0.74 pct

Yahoo and Microsoft (NasdaqGS: MSFT - news) search engines temporarily went dark on Friday after Microsoft pushed out a bad code update and then struggled to roll it back, a person briefed on the outages told Reuters.

** NVIDIA CORP, $20.08, -0.25 pct

The chipmaker on Sunday unveiled a new processor aimed at powering high-end graphics on car dashboards as well as sophisticated auto-pilot systems.

** CINEMARK HOLDINGS INC (NYSE: CNK - news) , $34.31, -1.72 pct

The movie theater chain's shares could rise more than 25 percent over the next year, Barron's reported in its Jan. 5 edition.

** DREAMWORKS ANIMATION SKG INC (NasdaqGS: DWA - news) , $22.5074, -0.63 pct

The Hollywood movie studio said it has appointed new co-presidents of feature animation, while its chief creative officer is stepping down.

** NTT DOCOMO INC (NYSE: DCM - news) , $14.49, -1.09 pct

The company said it has asked a London court to ensure Tata Sons Ltd finds a buyer willing to pay at least $1.1 billion for the Japanese carrier's stake in a struggling Indian joint venture. (Compiled by Lehar Maan; Editing by Joyjeet Das)